Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Locations sections listing participating sites across many US states and Canadian provinces. Revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check28 days agoNo Change Detected
- Check49 days agoChange Detected- The Publications section now states that publications are automatically filled in from PubMed and may not all pertain to the study, replacing the prior description. - A Revision: v3.3.2 tag was added.SummaryDifference0.0%

- Check57 days agoChange DetectedRemoved a government funding/status banner from the page. The study details and navigation remain unchanged.SummaryDifference0.1%

- Check78 days agoChange DetectedThe new screenshot preserves the same study details and sections as the previous image, with only minor formatting or layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check99 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%

- Check107 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.